Detalles de la búsqueda
1.
Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells.
Int J Mol Sci
; 21(14)2020 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32708306
2.
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.
Tumour Biol
; 39(4): 1010428317695023, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28378631
3.
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance.
Mol Cancer
; 13: 143, 2014 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24898067
4.
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines.
Mol Cancer
; 11: 91, 2012 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23234355
5.
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines.
Front Oncol
; 10: 563249, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33072590
6.
Efficacy of the CDK4/6 Dual Inhibitor Abemaciclib in EGFR-Mutated NSCLC Cell Lines with Different Resistance Mechanisms to Osimertinib.
Cancers (Basel)
; 13(1)2020 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33374971
7.
Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer.
Cancers (Basel)
; 12(3)2020 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32178474
8.
PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition.
Cancers (Basel)
; 11(9)2019 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31500143
9.
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells.
Sci Rep
; 9(1): 13014, 2019 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31506466
10.
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion.
Target Oncol
; 14(5): 619-626, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31502118
11.
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines.
Front Oncol
; 9: 179, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30972293
12.
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC.
J Exp Clin Cancer Res
; 38(1): 222, 2019 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31138260
13.
CDK4/6 inhibitors in HER2-positive breast cancer.
Crit Rev Oncol Hematol
; 112: 208-214, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28325261
14.
Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands.
Eur J Med Chem
; 128: 140-153, 2017 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28182987
15.
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines.
J Exp Clin Cancer Res
; 36(1): 174, 2017 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29202823
16.
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.
Oncotarget
; 8(54): 91841-91859, 2017 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29190880
17.
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN.
Oncotarget
; 8(32): 53068-53083, 2017 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28881794
18.
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells.
Neoplasia
; 19(8): 637-648, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28704762
19.
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation.
J Thorac Oncol
; 11(7): 1051-63, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27006151
20.
Drug-induced cellular death dynamics monitored by a highly sensitive organic electrochemical system.
Biosens Bioelectron
; 68: 791-797, 2015 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25687585